compounded tirzepatide vs semaglutide Injections $100 Tirzepatide vs Semaglutide: Key Differences

Protein adequacy becomes critical during this phase

Tirzepatide, marketed as Mounjaro, and semaglutide, marketed as Wegovy, both have MHRA authorisation for weight management

Not all supplements are created equal

What makes retatrutide different from other weight-loss drugs is that it is a 'triple agonist,' meaning it targets three hormones (GLP-1, GIP, and glucagon) that reduce your appetite, increase calorie burning, and help control your blood sugar

The rationale is practical: the B12 component can reduce injection-site irritation for some patients and may support those who are B12-deficient

Retatrutide is an investigational GLP-1, GIP, and glucagon triple receptor agonist available only through authorised clinical trials